Comparative effectiveness research in childhood infections to improve decision-making in health policy and clinical practice.

很少有关于儿童抗生素和疫苗的高质量研究被完成，因为它们很困难，而且公司几乎没有商业动机来资助它们。这减缓了治疗和预防感染的更好方法的发展，包括那些对土著儿童最重要的方法。我将通过对儿童的新疗法和疫苗进行高质量的研究来满足这一需求，以促进它们迅速付诸实践。

Few high quality studies of antibiotics and vaccines in children are done because they are difficult, and because there is little commercial incentive for companies to fund them. This has slowed the development of better ways to treat and prevent infections, including those which are most important for Aboriginal children. I will address this need by doing high quality studies of new treatments and vaccines in children in a way that will facilitate their rapid adoption into practice.